R. Mark Jones

2.0k total citations
54 papers, 1.4k citations indexed

About

R. Mark Jones is a scholar working on Molecular Biology, Biotechnology and Infectious Diseases. According to data from OpenAlex, R. Mark Jones has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Biotechnology and 13 papers in Infectious Diseases. Recurrent topics in R. Mark Jones's work include Transgenic Plants and Applications (19 papers), Mosquito-borne diseases and control (10 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). R. Mark Jones is often cited by papers focused on Transgenic Plants and Applications (19 papers), Mosquito-borne diseases and control (10 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). R. Mark Jones collaborates with scholars based in United States, Netherlands and Switzerland. R. Mark Jones's co-authors include Vidadi Yusibov, Jessica A. Chichester, Stephen J. Streatfield, Diane A. Blake, Haini Yu, Konstantin Musiychuk, Robert C. Blake, Andrey R. Pavlov, Ibrahim A. Darwısh and Moneim Shamloul and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

R. Mark Jones

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Mark Jones United States 22 610 307 283 272 229 54 1.4k
Richard F. Rest United States 30 1.1k 1.8× 146 0.5× 245 0.9× 565 2.1× 346 1.5× 68 2.7k
Noriko Tomita Japan 30 944 1.5× 134 0.4× 167 0.6× 490 1.8× 541 2.4× 117 2.5k
Andrew J. Reason United Kingdom 19 1.0k 1.6× 92 0.3× 117 0.4× 280 1.0× 238 1.0× 34 1.7k
Andreas Frey Germany 19 770 1.3× 62 0.2× 101 0.4× 411 1.5× 258 1.1× 41 1.9k
Diane Thomas United States 21 506 0.8× 123 0.4× 130 0.5× 195 0.7× 276 1.2× 46 1.4k
Rajan Kumar Pandey India 23 1.6k 2.6× 310 1.0× 336 1.2× 490 1.8× 419 1.8× 54 2.1k
Eleonora Altman Canada 29 1.2k 2.0× 92 0.3× 96 0.3× 669 2.5× 139 0.6× 94 2.6k
Christian Heiß United States 30 1.2k 2.0× 182 0.6× 55 0.2× 278 1.0× 438 1.9× 89 2.5k
S. Swaminathan India 33 990 1.6× 248 0.8× 1.1k 4.0× 190 0.7× 1.0k 4.5× 76 2.6k
Jai K. Kaushik India 25 1.3k 2.2× 206 0.7× 124 0.4× 121 0.4× 69 0.3× 75 2.2k

Countries citing papers authored by R. Mark Jones

Since Specialization
Citations

This map shows the geographic impact of R. Mark Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Mark Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Mark Jones more than expected).

Fields of papers citing papers by R. Mark Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Mark Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Mark Jones. The network helps show where R. Mark Jones may publish in the future.

Co-authorship network of co-authors of R. Mark Jones

This figure shows the co-authorship network connecting the top 25 collaborators of R. Mark Jones. A scholar is included among the top collaborators of R. Mark Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Mark Jones. R. Mark Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paolino, Kristopher, Jason A. Regules, James E. Moon, et al.. (2022). Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adults. Vaccine. 40(12). 1864–1871. 14 indexed citations
2.
Ma, Shuyi, et al.. (2021). Experimental and Computational Workflow for RNA Sequencing in Mycobacterium tuberculosis: From Total RNA to Differentially Expressed Genes. Methods in molecular biology. 2314. 481–512. 3 indexed citations
3.
Jones, R. Mark, et al.. (2018). Vibrio fischeri DarR Directs Responses to d -Aspartate and Represents a Group of Similar LysR-Type Transcriptional Regulators. Journal of Bacteriology. 200(15). 12 indexed citations
4.
Chichester, Jessica A., Brian J. Green, R. Mark Jones, et al.. (2018). Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults. Vaccine. 36(39). 5865–5871. 90 indexed citations
6.
Blagborough, Andrew M., Konstantin Musiychuk, R. Mark Jones, et al.. (2016). Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax. Vaccine. 34(28). 3252–3259. 21 indexed citations
7.
Seid, Christopher A., Elena Curti, R. Mark Jones, et al.. (2015). Expression, purification, and characterization of theNecator americanusaspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine. Human Vaccines & Immunotherapeutics. 11(6). 1474–1488. 28 indexed citations
8.
Jones, R. Mark, Jessica A. Chichester, Slobodanka D. Manceva, et al.. (2014). A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses. Human Vaccines & Immunotherapeutics. 11(1). 124–132. 32 indexed citations
9.
Shôji, Yôko, R. Mark Jones, Vadim Mett, et al.. (2013). A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge. Human Vaccines & Immunotherapeutics. 9(3). 553–560. 24 indexed citations
10.
Musiychuk, Konstantin, Hong Bi, R. Mark Jones, et al.. (2013). Plant-Produced Human Recombinant Erythropoietic Growth Factors Support Erythroid Differentiation In Vitro. Stem Cells and Development. 22(16). 2326–2340. 15 indexed citations
11.
Mamedov, Tarlan, R. Mark Jones, Vadim Mett, et al.. (2012). Production of non‐glycosylated recombinant proteins in Nicotiana benthamiana plants by co‐expressing bacterial PNGase F. Plant Biotechnology Journal. 10(7). 773–782. 34 indexed citations
12.
Iyer, Vidyashankara, Yôko Shôji, Jessica A. Chichester, et al.. (2012). Formulation development of a plant-derived h1n1 influenza vaccine containing purified recombinant hemagglutinin antigen. Human Vaccines & Immunotherapeutics. 8(4). 453–464. 12 indexed citations
13.
Farrance, Christine E., Jessica A. Chichester, Konstantin Musiychuk, et al.. (2011). Antibodies to plant-producedPlasmodium falciparumsexual stage protein Pfs25 exhibit transmission blocking activity. Human Vaccines. 7(sup1). 191–198. 55 indexed citations
14.
Jones, R. Mark, et al.. (2008). A Human Monoclonal Antibody that Binds Serotype A Botulinum Neurotoxin. Hybridoma. 27(1). 11–17. 17 indexed citations
15.
Jones, R. Mark, et al.. (2008). Hybridoma populations enriched for affinity-matured human IgGs yield high-affinity antibodies specific for botulinum neurotoxins. Journal of Immunological Methods. 333(1-2). 156–166. 28 indexed citations
16.
Takahashi, Tsuyoshi, R. Mark Jones, Fetweh H. Al‐Saleem, et al.. (2008). Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain. PLoS ONE. 3(8). e3023–e3023. 56 indexed citations
17.
Kanyo, Z.F., R. Mark Jones, Robert J. Fletterick, et al.. (2006). Directed Evolution of an Anti-prion Protein scFv Fragment to an Affinity of 1 pM and its Structural Interpretation. Journal of Molecular Biology. 363(1). 75–97. 76 indexed citations
18.
Blake, Diane A., R. Mark Jones, Robert C. Blake, et al.. (2001). Antibody-based sensors for heavy metal ions. Biosensors and Bioelectronics. 16(9-12). 799–809. 139 indexed citations
19.
Dawson, William O., J. R. O. Dawson, R. Mark Jones, Kim Ward, & Lawrence S. Young. (1998). Functional Differences between BHRF1, the Epstein-Barr Virus-Encoded Bcl-2 Homologue, and Bcl-2 in Human Epithelial Cells. Journal of Virology. 72(11). 9016–9024. 34 indexed citations
20.
Cameron, Dawn M., S.J. Rance, R. Mark Jones, & D. A. Charles‐Edwards. (1991). Trees and pasture: a study on the effects of spacing. 3(1). 8–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026